2 in 1 protection against canine influenza which facilitates vaccination protocols
Reduces the incidence and severity of coughing86
Decreases the overall clinical signs of disease, including ocular and nasal discharge, coughing, sneezing, depression, and dyspnea86
Demonstrates protection against the formation and severity of lung lesions86
Contains inactivated virus. Adjuvanted to enhance immune response
INDICATIONS:
This product has been shown to be effective for vaccination of healthy dogs 7 weeks of age or older against canine influenza virus.
CANINE FLU BIVALENT IS A SAFE CHOICE
Safety confirmed through clinical use1
Well tolerated on subcutaneous administration
Proven safe across a multitude of dog breeds and ages
Nobivac® Canine Flu Bivalent was shown to be 99.1% reaction-free in the field safety trial1
ADMINISTRATION AND DOSAGE
1 mL subcutaneous injection
Booster two to four weeks later
Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. Contact your veterinarian or manufacturer for more information on revaccination frequency.
NOBIVAC® CANINE FLU BIVALENT –DUAL STRAINS FOR DUAL THREATS
Highly effective in reducing clinical signs of canine influenza infection
In a H3N2 challenge study, vaccinates exhibited significantly less lung consolidation and lung damage than control dogs
Demonstrated to prevent mortality from severe H3N2 challenge
No items to show.
Loading…
Professional Resources and Educational Materials
Keep your clinic and staff informed and aware of diseases and outbreaks.
Pair Up for Protection
Infographic
When it comes to dogs in social environments, respiratory protection is essential. Use this conversation starter to discuss full respiratory protection with your clients.
